Preexisting Resistance to Nonnucleoside Reverse‐Transcriptase Inhibitors Predicts Virologic Failure of an Efavirenz‐Based Regimen in Treatment‐Naive HIV‐1–Infected Subjects
Open Access
- 15 March 2008
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 197 (6) , 867-870
- https://doi.org/10.1086/528802
Abstract
A case-cohort study was used to determine the effect of baseline nonnucleoside reverse-transcriptase inhibitor (NNRTI) resistance, as assessed by virKeywords
This publication has 13 references indexed in Scilit:
- Three- vs Four-Drug Antiretroviral Regimens for the Initial Treatment of HIV-1 InfectionA Randomized Controlled TrialJAMA, 2006
- The impact of transmitted drug resistance on the natural history of HIV infection and response to first-line therapyAIDS, 2006
- Should Resistance Testing Be Performed for Treatment-Naive HIV-Infected Patients? A Cost-Effectiveness AnalysisClinical Infectious Diseases, 2005
- Efficacy and Safety of Emtricitabine vs Stavudine in Combination Therapy in Antiretroviral-Naive PatientsA Randomized TrialPublished by American Medical Association (AMA) ,2004
- The Epidemiology of Antiretroviral Drug Resistance among Drug‐Naive HIV‐1–Infected Persons in 10 US CitiesThe Journal of Infectious Diseases, 2004
- Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapyAIDS, 2004
- Antiretroviral Drug Resistance Testing in Adults Infected with Human Immunodeficiency Virus Type 1: 2003 Recommendations of an International AIDS Society–USA PanelClinical Infectious Diseases, 2003
- Antiretroviral-Drug Resistance among Patients Recently Infected with HIVNew England Journal of Medicine, 2002
- Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapyAIDS, 1999
- Analysis of Case-Cohort DesignsJournal of Clinical Epidemiology, 1999